AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 191 min read$DK

Soreq Avigal sold $5.3M of DK

Soreq Avigal (President & CEO) sold 80,000 shares of Delek US Holdings, Inc. (DK) at an average of $66.51 ($64.38–$67.20, $5.32M total) across 4 trades on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Soreq Avigal
Published Aug 19, 2026, 12:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 12:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$DK
Neutral
medium confidence
Mentioned
$DK
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DKNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but this filing alone does not provide new operational or financial information.

02

Market read

A CEO open-market sale of $5.32M worth of DK shares was disclosed, with trades executed on 2026-08-17.

03

What to watch

The filing does not disclose why the CEO sold or whether other insiders/large holders changed positions around the same time.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-18 for trades dated 2026-08-17

Background

The article is an SEC Form 4 insider transaction disclosure for Delek US Holdings, Inc.

Company-level read

Ticker impact

$DKNeutralMedium confidence
Context

Delek US Holdings CEO Soreq Avigal sold about $5.32M of DK shares via an open-market sale under a 10b5-1 plan.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

Form 4 shows a pre-arranged 10b5-1 sale by the CEO; such sales are often routine and do not by themselves change earnings or guidance.

Market effects

Sector

No clear sector read-through from a single CEO 10b5-1 sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale is under a pre-arranged 10b5-1 plan, so it may reflect liquidity planning rather than bearish expectations.

Key entities

  • issuer
    Delek US Holdings, Inc.

    Subject of the Form 4 insider sale disclosure (DK).

  • insider
    Soreq Avigal

    President and CEO who executed open-market sales under a 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

DK insider trading history →

Related articles

SEP 14
$MPCMed

BTIG warns oil refining stocks face potential correction after record gains

BTIG warns that oil refining stocks may face a correction after the S&P 500 Oil & Gas Refining and Marketing Index gained 124% year-to-date, its best performance in 30 years. The index is 122% above its 200-week moving average, with a weekly RSI of 81. Historically, similar conditions led to declines 7 out of 8 times, with a median 12-week return of -7.2%. BTIG identifies Marathon Petroleum, Valero, Phillips 66, PBF Energy, and Delek Holdings as having poor risk-reward profiles.

investing.com2 min
SEP 9
$DKMed

Why Delek Holdings Stock Triumphed on Tuesday

Delek US Holdings (DK) will join the S&P SmallCap 600 index on Sept. 21, replacing Brinker International. The stock rose over 5% on the news, likely due to increased visibility and potential index fund inclusion. The change does not alter the company's fundamentals.

aol.com2 min
AUG 24
$DKMed

Is DK a Buy Now as Cash Flow Improves Despite Refining Cycle Risks?

Delek US Holdings (DK) reported improved cash flow in Q2, with $262.9M from operations. Management expects $220M annual free-cash-flow improvement. DK trades at a forward P/E of 7.1 and P/S of 0.36. Risks include leverage, crack-spread volatility, and regulatory uncertainty. Zacks ranks DK as a Strong Buy with A-rated Value and Growth scores.

tradingview.com3 min
AUG 23
$DKMedAI 8/10

Up another 12% Friday, this AI-picked energy stock is now up +90%

Delek US Holdings (DK) surged 11.6% on Friday, reaching near a 52-week high of $71.47, extending its 90% gain since March. The energy company reported Q2 EPS of $5.48, beating estimates by 148%, with EBITDA up 279% quarter-over-quarter. InvestingPro's AI models identified Delek's potential before its rally, citing strong momentum, earnings turnaround, and cost discipline. The company's performance highlights include record refining margins and operational improvements. InvestingPro members recei

investing.com2 min